Anti-apoptotic role of HIF-1 and AP-1 in paclitaxel exposed breast cancer cells under hypoxia.

Molecular Cancer
Lionel FlamantCarine Michiels

Abstract

Hypoxia is a hallmark of solid tumors and is associated with metastases, therapeutic resistance and poor patient survival. In this study, we showed that hypoxia protected MDA-MB-231 breast cancer cells against paclitaxel- but not epirubicin-induced apoptosis. The possible implication of HIF-1 and AP-1 in the hypoxia-induced anti-apoptotic pathway was investigated by the use of specific siRNA. Specific inhibition of the expression of these two transcription factors was shown to increase apoptosis induced by chemotherapeutic agents under hypoxia indicating an involvement of HIF-1 and AP-1 in the anti-apoptotic effect of hypoxia. After HIF-1 specific inhibition and using TaqMan Human Apoptosis Array, 8 potential HIF-1 target genes were identified which could take part in this protection. Furthermore, Mcl-1 was shown to be a potential AP-1 target gene which could also participate to the hypoxia-induced chemoresistance. Altogether, these data highlight two mechanisms by which hypoxia could mediate its protective role via the activation of two transcription factors and, consecutively, changes in gene expression encoding different anti- and pro-apoptotic proteins.

References

Mar 7, 1990·Journal of the National Cancer Institute·J M Brown
Apr 15, 1989·Biochemical Pharmacology·S J Duthie, M H Grant
Jan 1, 1980·Biochemical Pharmacology·K A KennedyA C Sartorelli
Jun 6, 1995·Proceedings of the National Academy of Sciences of the United States of America·G L WangG L Semenza
Jun 1, 1994·Cancer Metastasis Reviews·B A Teicher
Jul 15, 1993·International Journal of Radiation Oncology, Biology, Physics·P OkunieffP Vaupel
Jan 24, 1998·Science·A J GiacciaC Koumenis
Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·L E HuangH F Bunn
Nov 2, 1999·Cancer Treatment Reviews·N KrögerA R Zander
May 16, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M VenturiniM Esposito
Aug 2, 2000·Proceedings of the National Academy of Sciences of the United States of America·R K Bruick
Oct 14, 2000·The Journal of Biological Chemistry·J LozanoR Kolesnick
Feb 22, 2001·Journal of the National Cancer Institute·M Höckel, P Vaupel
Feb 24, 2001·Journal of Radiation Research·O GrecoG U Dachs
Jul 4, 2001·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E D Razis, G Fountzilas
Mar 12, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G LunardiM Esposito
Mar 21, 2002·Nature Reviews. Cancer·Adrian L Harris
Sep 6, 2002·Biochemical Pharmacology·Jean-Pascal PiretCarine Michiels
Mar 26, 2003·Cell Death and Differentiation·H N LeBlanc, A Ashkenazi
Jul 16, 2003·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Irina Vasilevskaya, Peter J O'Dwyer
Aug 21, 2003·Cancer Treatment Reviews·Aoife M ShannonDeirdre Toomey
Apr 6, 2004·Laboratory Investigation; a Journal of Technical Methods and Pathology·Erik Z YuRichard M McCarron
Apr 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kenji Yokoi, Isaiah J Fidler
Oct 12, 2004·The International Journal of Biochemistry & Cell Biology·Jorg MichelsGraham Packham
Jul 12, 2005·Pflügers Archiv : European journal of physiology·Eoin P Cummins, Cormac T Taylor
Oct 18, 2005·Journal of Cellular Biochemistry·Xiu-Huai LiuElliott Kagan
Nov 22, 2005·The Journal of Investigative Dermatology·Bahtier M KurbanovJürgen Eberle
Mar 8, 2006·Cancer Chemotherapy and Pharmacology·Bo YangQiaojun He
Jul 11, 2006·Journal of Mammary Gland Biology and Neoplasia·Yun Shin ChunYuman Fong
Jul 18, 2006·Experimental Cell Research·Jean-Pascal PiretCarine Michiels
Jan 9, 2007·Current Opinion in Genetics & Development·John D Gordan, M Celeste Simon
Apr 7, 2007·Cancer Metastasis Reviews·Jung-whan KimChi V Dang

❮ Previous
Next ❯

Citations

Mar 9, 2013·Cell Death & Disease·Y ZhaoM Tan
Jul 4, 2012·International Journal of Molecular Sciences·Zhu-Jun MaoYuan-Neng Chou
Dec 14, 2011·Oncology Reports·Šimon CiproTomáš Eckschlager
Jan 30, 2014·Breast Cancer Research : BCR·Armina A KaziAngela H Brodie
Oct 31, 2014·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Marie-Kristin von WahldeChristof Bernemann
Oct 30, 2015·International Journal of Molecular Sciences·Yu QiuChunyan Ji
Mar 18, 2015·Oncology Reports·Marina Gobbe MoschettaDebora Aparecida Pires De Campos Zuccari
Jan 22, 2015·Molecular Medicine Reports·Shanshan ShiShenglin Ma
Aug 1, 2015·Proceedings of the National Academy of Sciences of the United States of America·Haiquan LuGregg L Semenza
Mar 9, 2012·Trends in Pharmacological Sciences·Gregg L Semenza
Apr 7, 2011·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Nadine Rohwer, Thorsten Cramer
Dec 18, 2015·BBA Clinical·Elma A O'ReillyAmanda McCann
Apr 27, 2011·International Journal of Cancer. Journal International Du Cancer·Xiao-Qun YeGui-Sheng Qian
May 28, 2014·Journal of Biochemical and Molecular Toxicology·Yu GaoYan Sun
Aug 1, 2013·Acta histochemica·Larissa Bazela MaschioDebora Aparecida Pires de Campos Zuccari
Apr 25, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Hong-Ying LiaoSong-Wang Cai
Aug 29, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Norma Serrano-GarcíaCristina Trejo-Solís
Jul 9, 2013·Biochimica Et Biophysica Acta·Paolo PaoliPaola Chiarugi
Feb 17, 2015·Cancer Cell International·Elsa N Garza-TreviñoHerminia G Martínez-Rodríguez
Feb 15, 2012·Free Radical Biology & Medicine·Takaaki YamadaRyozo Oishi
Jan 31, 2015·Oncology Reports·Yoshinori ImamuraHironobu Minami
Apr 4, 2017·Biochimica Et Biophysica Acta. General Subjects·Jiří ŘehulkaViswanath Das
Aug 9, 2016·Human & Experimental Toxicology·H MalekinejadA Rezaei-Golmisheh
Jan 18, 2018·Journal of Biochemical and Molecular Toxicology·Ke WangTing Zhang
Nov 24, 2016·Frontiers in Plant Science·Sukhdev SinghAshok Kumar
Jun 28, 2016·Oncology Letters·Jucimara ColomboDebora Aparecida Pires Zuccari
Aug 11, 2020·Journal of Drug Targeting·Sepideh NezhadiFarid Dorkoosh
Dec 24, 2018·Frontiers in Pharmacology·Kathleen Schmit, Carine Michiels

❮ Previous
Next ❯

Datasets Mentioned

BETA
MDA-MB-231

Methods Mentioned

BETA
ELISA
confocal microscopy
PCR
transfection
Assay
Universal

Software Mentioned

SigmaStat
Primer Express

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis